MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Alpha synuclein BAC transgenic mice as a preclinical model for disease-modifying therapies in Parkinson’s disease

    H. Yamakado, S. Okuda, T. Taguchi, M. Ikuno, M. Uemura, N. Uemura, M. Hondo, M. Yanagisawa, R. Takahashi (Kyoto, Japan)

    Objective: The aim of this study is to make preclinical mice models for disease-modifying therapies in Parkinson's disease. Background: The prodromal stage of Parkinson's disease…
  • MDS Virtual Congress 2020

    Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders

    T. Kuusimäki, H. Al-Abdulrasul, S. Kurki, J. Hietala, S. Hartikainen, M. Koponen, A. Tolppanen, V. Kaasinen (Turku, Finland)

    Objective: To investigate the coincidence of Parkinson’s disease (PD) and schizophrenia spectrum disorders (SCD). Background: PD is characterized by a progressive loss of mesostriatal dopamine…
  • MDS Virtual Congress 2020

    Effect of Levodopa-Carbidopa Intestinal Gel Versus Optimized Medical Treatment on Dyskinesia in Advanced Parkinson’s Disease Patients: Final Results of the Randomized 12-Week DYSCOVER Study

    E.F Alvarez, C. Spanaki, E. Pekkonen, L. Manzanares, Y. Liu, O. Sánchez-Soliño, L. Barbato (Elche, Spain)

    Objective: This study evaluated the effectiveness of LCIG versus optimized medical treatment (OMT) on the duration and severity of dyskinesia in aPD patients. Background: Approximately…
  • MDS Virtual Congress 2020

    Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact of Concomitant Antiemetics and Dopamine Agonists on Nausea and Vomiting

    A. Ellenbogen, A. Nicholas, R. Hauser, P. Bhargava, E. Pappert, B. Navia (Farmington Hills, MI, USA)

    Objective: Analyze effect of concomitant antiemetics and dopamine agonists (DA) on nausea and vomiting (N/V) in patients receiving apomorphine sublingual film (APL-130277; APL) for on-demand…
  • MDS Virtual Congress 2020

    The Association of Taichi to Delayed Progression of Parkinson’s Disease

    P. Huang, G. Li, Y.C He, S.D Chen (Shanghai, China)

    Objective: To discover the effect of physical exercise on motor and non-motor symptoms in Parkinson’s disease (PD), and to explore whether physical exercise could delay…
  • MDS Virtual Congress 2020

    Morphological changes of retina in patients with Parkinson’s disease and the role of α-synuclein in retinal damage

    L. Man, Z. Wei (Chengdu, China)

    Objective: To analyze the characteristics of retinal structural changes in patients with PD by the noninvasive technology of OCT. Demonstrate the role of α-syn in pathological changes of…
  • MDS Virtual Congress 2020

    A Patient with Gait Disturbance Caused by Parkinson’s Disease: A Case Report

    M. Park, SS. Park, S.H Lee, C.Y Kim, I.W Choi, I.C Chae, H.R Yoo (Daejeon, Republic of Korea)

    Objective: It is well known that mental simulation of movement in the brain can facilitate motor rehabilitation. Our hypothesis is: can a direct, sequential stimulation…
  • MDS Virtual Congress 2020

    Longitudinal clinical and imaging characteristics of non-manifest LRRK2 carriers: The PPMI cohort

    T. Simuni, A. Siderowf, M. Brumm, C. Caspell, H. Cho, C. Coffey, T. Foroud, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, K. Marek, p. PPMI Investigators (Chicago, IL, USA)

    Objective: To examine longitudinal change in the clinical characteristics of non-manifesting LRRK2 mutation carriers (NMCs) compared to healthy controls (HC) in the Parkinson’s Progression Markers…
  • MDS Virtual Congress 2020

    Prevalence and Characteristics of Postural Deformities in Thai Patients with Parkinson’s Disease

    T. Wangthumrong, C. Pongmala, Y. Pitakpatapee, J. Srikajon, M. Vichutavate, P. Srivanitchpoom (Bangkok, Thailand)

    Objective: We aimed to investigate the prevalence, clinical characteristics and quality of life (QoL) in Thai Parkinson's disease (PD) patients with postural deformities (PostD) and…
  • MDS Virtual Congress 2020

    Deep brain stimulation lead position impact on parkinsonian non-motor symptoms

    J. Bardoň, S. Kurčová, M. Chudáčková, P. Otruba, D. Krahulík, M. Nevrlý, P. Kaňovský, J. Zapletalová, J. Valošek, P. Hluštík (Olomouc, Czech Republic)

    Objective: This study evaluated the direct impact of localization of deep brain stimulation electrodes active contact within the different parts of subthalamic nucleus on improvement…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley